Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnology with electronics comes with

Cigna’s exit from the ACA individual market is causing one healthcare expert to question the long-term potential of ICHRA. The post Could Cigna Exiting the

A new report from PayZen found that providers collect just 31% of patient bills on average, even as patient payments account for a growing share

When demand fluctuates, even slightly, the margin for error becomes clear – highlighting the urgent need for greater efficiency to meet rising procedural demand. The

Hospitals who prioritize patient understanding achieve better operational outcomes. Higher surgical conversion rates, increased patient retention, and repeat engagement produce measurable performance gains. The post

Delayed remediation and patch latency are no longer just IT and security metrics; they serve as direct reflections of leadership priorities. The post The Hidden